Eli Lilly and Co (WBO:LLYC) Accounts Payable & Accrued Expense : €14,174 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Eli Lilly and Co Accounts Payable & Accrued Expense?

Eli Lilly and Co's quarterly accounts payable & accrued expense increased from Jun. 2023 (€13,950 Mil) to Sep. 2023 (€14,931 Mil) but then declined from Sep. 2023 (€14,931 Mil) to Dec. 2023 (€14,174 Mil).

Eli Lilly and Co's annual accounts payable & accrued expense increased from Dec. 2021 (€8,433 Mil) to Dec. 2022 (€11,075 Mil) and increased from Dec. 2022 (€11,075 Mil) to Dec. 2023 (€14,174 Mil).

Eli Lilly and Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Eli Lilly and Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Accounts Payable & Accrued Expense Chart

Eli Lilly and Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6,453.90

7,172.28

8,432.99

11,074.91

14,174.07

Eli Lilly and Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															11,074.91	12,210.84	13,950.31	14,931.00	14,174.07

Eli Lilly and Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Eli Lilly and Co (WBO:LLYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (WBO:LLYC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

LLY:USA LLY:Mexico 1LLY:Italy LLY:Germany LLY:Switzerland LLY:Canada LILY34:Brazil LLY:Argentina

Address

Lilly Corporate Center, Indianapolis, IN, USA, 46285

Website

https://www.lilly.com

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (WBO:LLYC) Headlines

No Headlines